Practice-Changing Studies Presented at ASCO GI 2023

Rohit Gosain, MD, and Rahul Gosain, MD, known as the Oncology Brothers, talk highlights from ASCO GI 2023 with Mark Lewis, MD, a cancer survivor and director of gastrointestinal oncology at Intermountain Healthcare. Some of the studies covered include:

• The SPOTLIGHT analysis of zolbetuximab plus mFOLFOX6
• The randomized, phase III NAPOLI3 study, which assessed different treatment combinations in patients with metastatic pancreatic ductal adenocarcinoma
• The SUNLIGHT analysis of trifluridine/tipiracil plus bevacizumab for refractory metastatic colorectal cancer